Carregant...

Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models

BACKGROUND: Previous studies provide conflicting evidence on whether metformin is protective against cancer. When studying time-varying exposure to metformin, covariates such as body mass index (BMI) and glycated haemoglobin (HbA1c) may act as both confounders and causal pathway variables, and so ca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Epidemiol
Autors principals: Farmer, Ruth E, Ford, Deborah, Mathur, Rohini, Chaturvedi, Nish, Kaplan, Rick, Smeeth, Liam, Bhaskaran, Krishnan
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6469299/
https://ncbi.nlm.nih.gov/pubmed/30753459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ije/dyz005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!